SCHEMBL21716872

SCHEMBL21716872

c1ccc(-c2ccc(-c3nc4ccccc4nc3-n3c4ccc(-n5c6ccccc6c6c7ccccc7ccc65)cc4c4cc5ccccc5cc43)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
DHODH Q02127 2/20 0.32
PTGES O14684 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 2/20 0.32
HPGD P15428 2/20 0.32
NPY5R Q15761 1/20 0.31
LMNA P02545 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
RXFP1 Q9HBX9 2/20 0.31
MAPT P10636 1/20 0.31
GSR P00390 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716458 0.98 ESR1 (0.34) ESR1ESR2CASP1HSD17B10HRH4
SCHEMBL23471906 0.96 PTGES (0.33) ESR1ESR2CASP1HSD17B10HRH4
SCHEMBL21716227 0.95 ESR1 (0.33) ESR1ESR2CASP1HSD17B10HRH4
SCHEMBL23471882 0.94 ESR1 (0.33) ESR1ESR2CASP1HSD17B10HRH4
SCHEMBL24030552 0.94 HSD17B10 (0.35) CASP1HSD17B10HRH4DHODHPTGES
SCHEMBL18415403 0.93 PTGES (0.33) ESR1ESR2CASP1HSD17B10HRH4
SCHEMBL21716424 0.93 TUBB4A (0.32) DHODHPTGESKDM4EGAAHPGD
SCHEMBL23471638 0.93 HSD17B10 (0.34) CASP1HSD17B10HRH4DHODHPTGES
SCHEMBL21716897 0.93 L3MBTL1 (0.35) ESR1ESR2DHODHPTGESKDM4E
SCHEMBL18415421 0.93 HSD17B10 (0.36) ESR1ESR2CASP1HSD17B10HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 ESR1 195/4885ESR2 1326/4885CASP1 122/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 ESR1 195/4885ESR2 1326/4885CASP1 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.